Elidel-Study: Elidel in Patients With Atopic Dermatitis
NCT ID: NCT00180141
Last Updated: 2008-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
24 participants
INTERVENTIONAL
2005-04-30
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis
NCT01202149
Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
NCT00124709
LEO 29102 Cream in the Treatment of Atopic Dermatitis
NCT01037881
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
NCT01177566
Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis
NCT04976868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Elidel-Creme
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Atopic dermatitis on both lower arms at least 1% body surface area.
* Atopic Dermatitis Severity Index (ADSI)-Score \>= 6
* Investigator Global Assessment (IGA)-Score \>= 2
Exclusion Criteria
* Phototherapy against atopic dermatitis.
* Antibiotic therapy against atopic dermatitis.
* Allergy against Elidel.
* Pregnancy
* Nursing
* Skin cancer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Technical University Dresden
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roland Aschoff, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Dermatology. Medical Faculty, Technical University Dresden, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Technical University Dresden
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CASM981CDE16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.